Tauzin switches sides from drug industry overseer to lobbyist
676256
Retiring Rep. Billy Tauzin, R-La., who stepped down earlier this year as chairman of the House committee that regulates the pharmaceutical industry, will become
128752
The small business lobbying group that had a big part in derailing Hillary Clintonâs effort to overhaul health care in the early 1990s has staked out its position for the 2008 political season.
350813
TAP Pharmaceutical Products Inc.&#39;s new president starts today, about a month after he and others were acquitted of federal grand jury charges of kickbacks and conspiracy.
237707
The pharmaceutical industry on Wednesday named as its top lobbyist a longtime congressman who has been among those overseeing it. The new job is said to come with a $1 million-plus salary.
613309
The former chairman of the U.S.  House of Representatives Energy and Commerce Committee, who  earlier this year ended negotiations to head the pharmaceutical  industry's top lobby after critics questioned the ethics of the  move, has now accepted the post, the group said on Wednesday.
168037
Pfizer Inc.  abruptly replaced  Chief Executive Hank McKinnell on Friday, selecting its top  lawyer, Jeffrey Kindler, to run the world's largest drugmaker.
93543
Jack Valenti took a break from cleaning out his office the other day to expound on a subject he knows well: the art of persuasion. Over minestrone soup and hummus at his usual table at the restaurant in the Hay Adams Hotel, Valenti, the 82-year-old dean of Washington lobbyists, reflected on how Washington has changed and how lobbyists should operate here.
179256
Lobbying and other political spending by the pharmaceutical industry includes:
113028
Drugstore.com has had a tough year, but it has a big believer: its new CEO.
222383
New York Mayor Michael Bloomberg said on Tuesday he was changing his political status to independent from Republican.
735826
A new face in the boardroom heralds change for the troubled company.
321006
The Republican congressman who helped regulate the drug industry now works for it. A maverick Democratic senator who derided special interests has signed on with a law firm representing many of them. A former House Republican is president of one of the nation's largest lobbying operations.
219400
The former will take over development of the latter's drug.
714648
By Jose Pagliery, The Miami Herald  Feb. 8--After 10 years wading through bureaucracy in the healthcare industry, Mario Yanez had had enough. He longed to separate himself from what he considered the dull business world and connect to a life outside of the city's concrete buildings.
174323
U.S. customs officials will still seize prescription drugs imported from Canada through the mail but will hand over enforcement to federal health officials in a policy reversal that one lawmaker said would benefit consumers seeking cheaper medicines.
4220
Public reaction forced the drug manufacturer to ends its lobbying efforts in state legislatures on behalf of a vaccine.
15160
The Swiss pharmaceutical company Roche Holding said its chief executive would step down next March as the company separates that job from the chairmanâs position. Franz B. Humer, who has been chief since 1998, will remain chairman of the board. Next July, he also will become chairman of the beverage company Diageo. He will be succeeded by Severin Schwan, 40, who had been the head of Rocheâs diagnostics unit since January. The company also posted a 24 percent increase in first-half net profit, to 4.92 billion Swiss francs ($4.1 billion) from 3.97 billion francs in the period a year earlier. Roche benefited from its flu treatment Tamiflu as governments stockpile the drug in case of an influenza pandemic.